Inspyr

Inspyr

Inspyr

GenSpera, Inc. (OTCQB: $GNSZ) is a development stage oncology company focused on therapeutics that deliver a potent, unique & patented drug directly to tumors.
Founded
2003
Raised
$3.6M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$2,500,000
Venture capital - 2015
$280,000
Venture capital - 2014
Team Size
2
Employees
Xconomy

Roundup: J&J and AT&T Grow in Houston, Inspyr and Meshify Move On

Funding Health
Xconomy

Inspyr Leaves San Antonio for California to Be Near Clinical Trials

Health City life
Xconomy

Inspyr Seeks Clinical Partner for Cash After New Name, Exec Hires

Health
Xconomy

Inspyr, Formerly GenSpera, Replaces Co-Founder Dionne With New CEO

Strategy Funding
Xconomy

GenSpera, Pursuing Partners, Tests Toxin-Based Drug in Brain Cancer

Health Science